HilleVax

Clinical-stage biopharmaceutical company developing vaccines for norovirus and other infectious diseases. Publicly traded on NASDAQ (HLVX).

Location
Cambridge, Massachusetts, USA
Founded
2019
Investors
1
Categories
biotech, vaccines, infectious-disease, public

Investors

NameLocationTypeStagesPortfolio
AbingworthLondon, UK / Boston, USAbiotech-focused
seedseries-a+3
34